Andreas Persidis is a successful entrepreneur and the co-founder and CEO of Biovista, a company that specializes in data-driven drug repositioning and drug discovery. Biovista utilizes artificial intelligence, bioinformatics, and other computational approaches to identify new therapeutic applications for existing drugs (drug repositioning) and to explore potential drug candidates for various diseases